Tyra Biosciences, Inc.TYRANASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
28.09%
↓ 75% below average
Average (5y)
111.79%
Historical baseline
Range
High:302.40%
Low:0.00%
Volatility
270.5%
High variability
| Period | Value |
|---|---|
| 2024 | 28.09% |
| 2023 | 45.36% |
| 2022 | 108.41% |
| 2021 | 186.49% |
| 2020 | 302.40% |
| 2019 | 0.00% |